ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
29 Dec 2021

Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue

Press release Malmö, December 29, 2021 Acarix carries out a directed issue of shares to guarantors in conjunction with completed ...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
20 Dec 2021

Acarix announce final outcome in rights issue

Press release Malmö, December 20, 2021 Acarix announce final outcome in rights issue Acarix AB ("Acarix" or the "Company") has c...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
30 Nov 2021

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acari...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
23 Nov 2021

Announcement from Acarix’s extra general meeting

Press release Malmö, November 23, 2021 Announcement from Acarix's extra general meeting The extra general meeting of Acarix AB (...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Q3, Regulatory, Report
November 18, 2024
11 Nov 2021

Acarix AB (publ) publishes Interim Report, January – September 2021

Press release Malmö, November 11, 2021 Acarix AB (publ) publishes Interim Report, January – September 2021 Positive trend ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
09 Nov 2021

Acarix accelerates US market entry with Proximo Medical as commercialization partner

  Press release (MAR)Malmö, Sweden, November 9, 2021 Acarix accelerates US market entry with Proximo Medical as commerciali...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
08 Nov 2021

Acarix US expansion to be a major contributor to the company’s new financial and operational goals

Press release (MAR)Malmö, Sweden, November 8, 2021 Acarix US expansion to be a major contributor to the company’s new fina...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
05 Nov 2021

Notice of Extra General Meeting in Acarix AB

Notice of Extra General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
05 Nov 2021

Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 million to expand on the US market

Press release (MAR) Malmö, Sweden, November 5, 2021 Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
27 Oct 2021

Acarix granted US CPT reimbursement code for CADScor System

Press release (MAR)Malmö, Sweden, October 27, 2021 Acarix granted US CPT reimbursement code for CADScor System The editorial pan...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Staff change
November 18, 2024
28 Sep 2021

ACARIX begins US expansion and appoints Helen Ljungdahl Round as President Acarix Inc

Press releaseNew York, USA, September 28, 2021 ACARIX begins US expansion and appoints Helen Ljungdahl Round as President Acarix Inc ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Staff change
November 18, 2024
14 Sep 2021

Acarix begins US expansion and appoints US President

        Press releaseMalmö, Sweden, September 14, 2021 Acarix begins US expansion and app...
Continue reading
  • «
  • ‹
  • 11
  • 12
  • 13
  • 14
  • 15
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.